Effect of a Hydrolyzed Rice Protein-based Formula on Growth, Tolerance, and Health-related Quality of Life in Infants With Cow's Milk Protein Allergy. (RIGHT-GO)
Effect of a Hydrolyzed Rice Protein-based Formula on Growth, Tolerance, and Health-related Quality of Life in Infants With Cow's Milk Protein Allergy: a Randomized Nutritional Clinical Study
Sponsor: Société des Produits Nestlé (SPN)
A NA clinical study on Cow Milk Protein Allergy, this trial is actively recruiting participants. The trial is conducted by Société des Produits Nestlé (SPN) and has accumulated 3 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
3 versions recorded-
Jan 2026 — Present [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2025 — Jan 2026 [monthly]
Not Yet Recruiting NA
-
Nov 2024 — Sep 2025 [monthly]
Not Yet Recruiting NA
First recorded
Oct 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Société des Produits Nestlé (SPN)
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Berlin, Germany , Bialystok, Poland , Bydgoszcz, Poland , Janki, Poland , Krakow, Poland , Lodz, Poland , Lublin, Poland , Naples, Italy , Parma, Italy , Pisa, Italy and 5 more locations